Considering this, it could potentially result in unhealthy levels of weight loss for those who are not obese
Prices are expected to level off as more companies pump more GLP-1 drugs into the market
Adv Exp Med Biol (2021) 1328:51322
PlexusDx's Precision Peptide Genetic Test identifies your specific regain risk profile, enabling proactive intervention strategies before discontinuation
To make an informed decision about compounded GLP-1 medications, you need to understand the legal framework that makes compounding possible, the specific regulatory actions that have shaped the current market, and the potential changes on the horizon
Clinical outcomes depend more on correct dosing, consistency, patient adherence, and metabolic factors than on whether the product is branded or compounded